Latest News and Press Releases
Want to stay updated on the latest news?
-
THE INFORMATION CONTAINED HEREIN IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN OR INTO AUSTRALIA, CANADA, ITALY, DENMARK, JAPAN, THE UNITED STATES, OR TO ANY NATIONAL OF SUCH JURISDICTIONS NB...
-
8 DECEMBER 2025 NORTHERN 3 VCT PLC TRANSACTION IN OWN SHARES Northern 3 VCT PLC (“the Company”) announces that on 5 December 2025 it purchased for cancellation under an existing authority granted...
-
Juniper Research has found that the number of customer interactions automated by AI agents will grow to more than 34 billion by 2027.
-
OSB GROUP PLC ISIN: GB00BLDRH36008 December 2025 LEI number: 213800ZBKL9BHSL2K459 OSB GROUP PLC (the “Company”) Transaction in Own Shares The Company...
-
LEI: 213800NNT42FFIZB1T09 8 December 2025 Transactions in Own Shares Foresight Group Holdings Limited ("Foresight", the "Group"), a leading investment manager in real assets and providing capital...
-
8 DECEMBER 2025 NORTHERN VENTURE TRUST PLC TRANSACTION IN OWN SHARES Northern Venture Trust PLC (“the Company”) announces that on 5 December 2025 it purchased for cancellation under an existing...
-
SHELL PLC THIRD QUARTER 2025 EURO AND GBP EQUIVALENT DIVIDEND PAYMENTS December 8, 2025 The Board of Shell plc today announced the pounds sterling and euro equivalent dividend payments in respect of...
-
ERJ Open Research article reports that Glasmacinal, a novel macrolide, was well tolerated and reduced neutrophilic inflammation in COPD patients.
-
8 DECEMBER 2025 NORTHERN 2 VCT PLC TRANSACTION IN OWN SHARES Northern 2 VCT PLC (“the Company”) announces that on 5 December 2025 it purchased for cancellation under an existing authority granted...
-
Pharming to participate in Oppenheimer Movers in Rare Disease Summit on Dec 11 in NYC. Chief Medical Officer Anurag Relan in fireside chat at 1:50 PM ET.